MedTrace Logo

Interest of PReOPerative Immunonutrition in Liver Surgery for Cancer

NCT02041871 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 399

Last updated 2018-10-11

No results posted yet for this study

Summary

To study the efficacy of preoperative immunonutrition in reducing postoperative morbidity after liver resection for cancer.

Conditions

  • Hepatectomy
  • Elective Hepatectomy
  • Malignant Tumors

Interventions

DIETARY_SUPPLEMENT

Oral immunonutrition

Powder 74g within 250ml of water, 3 times per day during 7 days before surgery

DIETARY_SUPPLEMENT

Placebo

Powder 74g within 250ml of water, 3 times per day during 7 days before surgery

Sponsors & Collaborators

  • Nestlé Foundation

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Denis CASTAING, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2018-09-13
Completion
2018-09-13

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02041871 on ClinicalTrials.gov